CN1086290C - 治疗尖锐湿疣的组合物 - Google Patents

治疗尖锐湿疣的组合物 Download PDF

Info

Publication number
CN1086290C
CN1086290C CN97122670A CN97122670A CN1086290C CN 1086290 C CN1086290 C CN 1086290C CN 97122670 A CN97122670 A CN 97122670A CN 97122670 A CN97122670 A CN 97122670A CN 1086290 C CN1086290 C CN 1086290C
Authority
CN
China
Prior art keywords
composition
catechin
infection
patients
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN97122670A
Other languages
English (en)
Chinese (zh)
Other versions
CN1185947A (zh
Inventor
程书钧
王德昌
原征彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Food Co ltd
Mitsui Norin Co Ltd
Original Assignee
Cancer Hospital and Institute of CAMS and PUMC
Mitsui Norin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Hospital and Institute of CAMS and PUMC, Mitsui Norin Co Ltd filed Critical Cancer Hospital and Institute of CAMS and PUMC
Publication of CN1185947A publication Critical patent/CN1185947A/zh
Application granted granted Critical
Publication of CN1086290C publication Critical patent/CN1086290C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
CN97122670A 1996-11-18 1997-11-17 治疗尖锐湿疣的组合物 Expired - Lifetime CN1086290C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP321195/96 1996-11-18
JP32119596A JP3213557B2 (ja) 1996-11-18 1996-11-18 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤

Publications (2)

Publication Number Publication Date
CN1185947A CN1185947A (zh) 1998-07-01
CN1086290C true CN1086290C (zh) 2002-06-19

Family

ID=18129859

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97122670A Expired - Lifetime CN1086290C (zh) 1996-11-18 1997-11-17 治疗尖锐湿疣的组合物

Country Status (13)

Country Link
US (1) US5795911A (2)
EP (1) EP0842660B1 (2)
JP (1) JP3213557B2 (2)
KR (1) KR100312252B1 (2)
CN (1) CN1086290C (2)
AT (1) ATE288266T1 (2)
AU (1) AU716120B2 (2)
CA (1) CA2221370C (2)
DE (2) DE69732402T2 (2)
ES (1) ES2232849T3 (2)
FR (1) FR12C0077I2 (2)
PT (1) PT842660E (2)
TW (1) TW371628B (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100337690C (zh) * 2005-02-07 2007-09-19 上海复旦张江生物医药股份有限公司 一种评价治疗尖锐湿疣药物有效性的方法
CN107530321A (zh) * 2015-03-19 2018-01-02 温迪·安妮·爱泼斯坦 针对女性性障碍的治疗化合物和治疗形式

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
US6197808B1 (en) * 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
CN1063957C (zh) 1997-09-29 2001-04-04 北京华颐中药制药厂 一种金荞麦制剂的制备方法
WO1999016319A1 (en) 1997-09-29 1999-04-08 China Innovation Center For Life Science (Usa) A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof
EP0938897A1 (en) * 1997-12-26 1999-09-01 Japanese Foundation For Cancer Research Telomerase inhibitor
US6030622A (en) * 1998-06-23 2000-02-29 Shehadeh; Ahmad Abdallah Herbal extract composition and method with immune-boosting capability
EP1100496A4 (en) * 1998-07-21 2002-10-23 Univ Jefferson SMALL MOLECULES INHIBIT THE BCL-2 PROTEINS
KR100319973B1 (ko) * 1998-12-05 2002-04-22 이인수 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물
ATE466577T1 (de) 2001-05-03 2010-05-15 Cornell Res Foundation Inc Behandlung von krankheiten, die durch hpv verursacht werden
DE10156794B4 (de) 2001-11-19 2006-05-18 Medigene Ag Arzneimittel zur Behandlung von Warzen
WO2003043628A1 (de) * 2001-11-19 2003-05-30 Medigene Aktiengesellschaft Arzneimittel zur behandlung von viralen haut- und tumorerkrankungen
US7108868B2 (en) * 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
CN101837003B (zh) * 2002-04-30 2013-09-04 尤尼根公司 作为治疗剂的包含无取代b环类黄酮和黄烷混合物的组合物
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US7780992B2 (en) 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
BRPI0409179A (pt) * 2003-04-04 2006-05-02 Unigen Pharmaceuticals Inc formulação de inibidores duplos de ciclooxigenase (cox) e lipoxigenase (lox) para cuidados com a pele de mamìferos
US7763588B2 (en) * 2003-06-13 2010-07-27 The Salk Institute For Biological Studies Method for increasing cognitive function and neurogenesis
MXPA06002456A (es) * 2003-09-02 2006-08-31 Unigen Pharmaceuticals Inc Formulacion de una mezcla de flavonoides con el aniillo b libre y flavanos para utilizarse en la prevencion y tratamiento de la declinacion cognoscitiva y el deterioro de la memoria relacionado con la edad.
BRPI0415215B8 (pt) 2003-10-09 2021-05-25 Medigene Ag uso de polifenol na preparação de medicamento
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
US20070082073A1 (en) * 2005-05-18 2007-04-12 University Of South Florida Catechin Adjuvants
US8044098B2 (en) * 2005-08-02 2011-10-25 Shenghua Guangzhou Pharmaceutical Science & Technology Co., Ltd. Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection
KR100801891B1 (ko) 2006-11-02 2008-02-12 한상진 천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물
EP2179722A1 (en) 2008-10-24 2010-04-28 Heinrich-Pette-Institut für experimentelle Virologie und Immunologie Topical formation for preventing sexual transmission of viral infection
ES2349966B1 (es) * 2008-10-30 2011-11-18 Ignacio Umbert Millet Formulaciones topicas para el tratamiento de verrugas.
US20110218241A1 (en) * 2010-03-06 2011-09-08 Cacao Bio-Technologies, Llc Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
WO2012100835A1 (en) 2011-01-28 2012-08-02 Laboratorios Del Dr. Esteve, S.A. Methods and compositions for the treatment of aids
US10806826B2 (en) 2013-01-09 2020-10-20 Bacterin International, Inc. Bone graft substitute containing a temporary contrast agent and a method of generating such and a method of use thereof
MX367243B (es) * 2016-02-04 2019-08-09 Maria Del Carmen Ramirez Olvera COMPOSICIÓN DE EXTRACTOS DE PLANTAS QUE INCREMENTAN LOS BACILOS DE DöDERLEIN, USADA PARA EL TRATAMIENTO DE ENFERMEDADES DE TRANSMISIÓN SEXUAL (ETS) Y DEL VIRUS DEL PAPILOMA HUMANO (VPH), CON EFECTO AFRODISIACO.
CN106727275A (zh) * 2016-12-15 2017-05-31 珠海聚焦先导生物研究院有限公司 一种治疗阴道炎的栓剂组合物
CN107349197A (zh) * 2017-07-13 2017-11-17 黄冈师范学院 一种儿茶素在制备治疗皮肤乳头状瘤的药物上的应用
IT202200013867A1 (it) 2022-06-30 2023-12-30 Lo Li Pharma Srl Composizione per il trattamento dell’ infezione da papilloma virus (hpv)
US12111395B2 (en) * 2023-01-30 2024-10-08 Semiconductor Components Industries, Llc Acoustic sensing of proximate obstacles
WO2025227040A1 (en) * 2024-04-26 2025-10-30 Amplexd Therapeutics, Inc. Pharmaceutical compositions and methods for treatment of intraepithelial dysplasia and neoplasia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2128207B1 (2) * 1971-03-11 1974-08-02 Zyma Sa
US5159069A (en) * 1988-12-20 1992-10-27 Yamanouchi Pharmaceutical Co., Ltd. Sulfated tannins and their salts
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
JPH03141220A (ja) * 1989-10-26 1991-06-17 Tsumura & Co 抗レトロウイルス剤
JP3019996B2 (ja) * 1990-03-01 2000-03-15 三井農林株式会社 白癬治療剤
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
DE4211238C2 (de) * 1992-04-03 1994-10-27 Edward I Budowskij Verwendung von 2',5'-Oligoadenylaten zur Behandlung von Papillomatosen
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
GB2293548A (en) * 1994-09-29 1996-04-03 Joan Louise Hibberd Treatment of herpes infections
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
JPH1036260A (ja) * 1996-07-18 1998-02-10 Mitsui Norin Kk 抗ガン剤の効力増強方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CA 116:207381 1991.1.1 ATSUSHI M.INHIBITION OF ROTAVIRUS AND ENTERUS AND ENTEROVIRUS THE INFECTIO *
CA 116:207381 1991.1.1 ATSUSHI M.INHIBITION OF ROTAVIRUS AND ENTERUS AND ENTEROVIRUS THE INFECTIO;CA 120;153052 1993.1.1 MIKIO N.INHIBITION OF THE INFECTIVITY OF INFLUENZA VIRUS BY TEA POLYPHENOL *
CA 120;153052 1993.1.1 MIKIO N.INHIBITION OF THE INFECTIVITY OF INFLUENZA VIRUS BY TEA POLYPHENOL *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100337690C (zh) * 2005-02-07 2007-09-19 上海复旦张江生物医药股份有限公司 一种评价治疗尖锐湿疣药物有效性的方法
CN107530321A (zh) * 2015-03-19 2018-01-02 温迪·安妮·爱泼斯坦 针对女性性障碍的治疗化合物和治疗形式
CN107530321B (zh) * 2015-03-19 2022-12-30 Gto制药有限责任公司 针对女性性障碍的治疗化合物和治疗形式

Also Published As

Publication number Publication date
DE122009000072I2 (de) 2011-07-21
PT842660E (pt) 2005-05-31
KR19980042555A (ko) 1998-08-17
DE122009000072I1 (de) 2010-03-25
CN1185947A (zh) 1998-07-01
CA2221370A1 (en) 1998-05-18
EP0842660A1 (en) 1998-05-20
DE69732402D1 (de) 2005-03-10
TW371628B (en) 1999-10-11
EP0842660B1 (en) 2005-02-02
ATE288266T1 (de) 2005-02-15
JPH10147525A (ja) 1998-06-02
US5795911A (en) 1998-08-18
JP3213557B2 (ja) 2001-10-02
ES2232849T3 (es) 2005-06-01
AU4443897A (en) 1998-06-04
DE69732402T2 (de) 2006-01-19
KR100312252B1 (ko) 2002-02-19
CA2221370C (en) 2004-03-02
FR12C0077I2 (fr) 2013-08-16
AU716120B2 (en) 2000-02-17
FR12C0077I1 (2) 2013-02-01

Similar Documents

Publication Publication Date Title
CN1086290C (zh) 治疗尖锐湿疣的组合物
CN101843614B (zh) 甲硝哒唑或其药学上可接受的衍生物的用途
Riva et al. Extended carbon dioxide laser vaporization in the treatment of subclinical papillomavirus infection of the lower genital tract
US5968973A (en) Method for treating hyperplasia
US6197808B1 (en) Methods for treating hyperplasia
Mayeaux Jr et al. Noncervical human papillomavirus genital infections.
Gross et al. Genitoanal lesions
Gantt et al. Progestin reversal of ureteral endometriosis
US10543228B2 (en) Pharmaceutical preparation containing selenite or selenite-containing compounds for treating cervical dysplasia or carcinomas
JP5211073B2 (ja) 子宮内膜症の治療用の薬剤
WO2000033832A1 (en) Chemical composition for treating cervical intraepithelial neoplasia i, ii, iii, iv and cervicitis
Maymon et al. Penile condylomata: a gynecological epidemic disease: a review of the current approach and management aspects
Krebs Genital HPV infections in men
Comite et al. Colposcopic evaluation of men with genital warts
RU2738550C1 (ru) Способ лечения больных с хроническими дистрофическими заболеваниями вульвы и шейки матки
CN113082032B (zh) Trpv4激动剂的新应用
JP2002512969A (ja) マイコバクテリウム属菌を使用する、乳頭腫ウイルス感染症の治療
Ahmed et al. Giant condyloma acuminatum of vulva
von Krogh Current treatment of genital warts
Peri et al. laser vaporization
Simonetti et al. Fournier's Gangrene: a Case Report

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: NITTO FOOD CO., LTD.

Free format text: FORMER NAME OR ADDRESS: MITSUI NORIN KK

Owner name: MITSUI NORIN KK

Free format text: FORMER NAME OR ADDRESS: NITTO FOOD CO., LTD.

CP01 Change in the name or title of a patent holder

Patentee after: Nitto Food Co.,Ltd.

Patentee before: Mitsui Norin Co.,Ltd.

Patentee after: Mitsui Norin Co.,Ltd.

Patentee before: Nitto Food Co.,Ltd.

CX01 Expiry of patent term

Granted publication date: 20020619